Showing results (801-810 of 864) with videos related to
Sort By:
Pageof 87
Current Drug Discovery Technologies|February 14, 2006
The characterisation of the collagenolytic activity of cardosin a demonstrates its potential application for extracellular matrix degradative processesAna S Duarte, Anabela O Pereira, António M S Cabrita, et al.Current Drug Discovery Technologies|February 14, 2006
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modelingEdwin J Matthews, Naomi L Kruhlak, James L Weaver, et al.Current Drug Discovery Technologies|February 14, 2006
Present status and future prospects of chemotherapeutics for intractable infections due to Mycobacterium avium complexHaruaki TomiokaCurrent Drug Discovery Technologies|February 14, 2006
Mass spectrometry in drug discovery: a current reviewWan Yong FengCurrent Drug Discovery Technologies|February 14, 2006
Efficient optimization strategy for marginal hits active against abl tyrosine kinasesSergey E Tkachenko, Ilya Okun, Konstantin V Balakin, et al.Current Drug Discovery Technologies|February 14, 2006
Is phage display technology on target for developing peptide-based cancer drugs?Linda A Landon, Jun Zou, Susan L DeutscherCurrent Drug Discovery Technologies|February 14, 2006
Probing protein binding sites by circular dichroism spectroscopyFerenc Zsila, Zsolt Bikádi, Ilona Fitos, et al.Current Drug Discovery Technologies|February 14, 2006
Intramolecular hydrogen bonding in depsipeptides containing endo-3,6-tricyclo[6.2.1.0(2,7)]undeca-4,9-diene-3,6-endo-diolMariane Axt, Hassan Oulyadi, Xavier Pannecoucke, et al.Current Drug Discovery Technologies|March 3, 2021
The Development of New Low-Molecular-Weight Factor Xa Inhibitors that are Potential AnticoagulantsDmitry G Tovbin, Dmitry N Tarasov, Dmitry V Malakhov, et al.Current Drug Discovery Technologies|January 22, 2014
Different approaches for obtaining antibodies from human B cellsMarcus R Duvall, Ryan N FioriniPageof 87